Laura Meis

Laura Meis is an Associate Professor at the University of Minnesota's Medical School with a primary appointment at the Veteran's Administration Medical Center. Her academic career focuses on improving mental health treatment outcomes for veterans, particularly those suffering from posttraumatic stress disorder (PTSD) and chronic pain conditions. She has established herself as a leading researcher in trauma-focused treatments and implementation science within veteran healthcare systems.

Dr. Meis's research interests center on PTSD treatment, trauma-focused therapy, chronic pain management, and mindfulness interventions specifically tailored for veteran populations. Her work emphasizes improving treatment adherence, reducing dropout rates, and enhancing quality of life outcomes through innovative approaches including partner-assisted prolonged exposure therapy and internet-based family training. She has developed methodologies for email recruitment in clinical trials and investigated gender differences in treatment response among veterans.

Her publication record shows consistent productivity with 63 research outputs spanning from 2008 to 2025, with particularly high output in recent years (9 publications in 2024 alone). The research demonstrates a clear trajectory from foundational work on PTSD symptoms and treatment mechanisms toward implementation science and practical strategies for improving real-world treatment delivery to veterans.

Dr. Meis serves as Principal Investigator on multiple significant research projects funded by the U.S. Department of Defense and the US Army Medical Research & Materiel Command. Her current active projects include 'A Hybrid-1 Effectiveness Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD' (2024-2028) and 'Reducing dropout and improving outcomes from PTSD therapy: When to switch therapies or stay the course' (2024-2028). She previously led 'Building a Family Systems Model to Promote Adherence' (2012-2016), demonstrating her long-standing commitment to improving PTSD treatment adherence among veterans.